A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 71, 209, 10.3322/caac.21660 Swami, 2020, Advanced prostate cancer: treatment advances and future directions, Trends Cancer, 6, 702, 10.1016/j.trecan.2020.04.010 Davis, 2019, Enzalutamide with standard first-line therapy in metastatic prostate cancer, N. Engl. J. Med., 381, 121, 10.1056/NEJMoa1903835 Hussain, 2018, Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer, N. Engl. J. Med., 378, 2465, 10.1056/NEJMoa1800536 Watson, 2015, Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer, Nat. Rev. Cancer, 15, 701, 10.1038/nrc4016 Arora, 2013, Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade, Cell, 155, 1309, 10.1016/j.cell.2013.11.012 Alumkal, 2020, Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance, Proc. Natl. Acad. Sci. USA, 117, 12315, 10.1073/pnas.1922207117 Beltran, 2016, Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer, Nat. Med., 22, 298, 10.1038/nm.4045 Shalem, 2014, Genome-scale CRISPR-Cas9 knockout screening in human cells, Science, 343, 84, 10.1126/science.1247005 Xu, 2020, ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer, Nat. Genet., 52, 198, 10.1038/s41588-019-0554-0 Jiang, 2018, Casein kinase 1alpha: biological mechanisms and theranostic potential, Cell Commun. Signal., 16, 23, 10.1186/s12964-018-0236-z Knippschild, 2014, The CK1 family: contribution to cellular stress response and its role in carcinogenesis, Front. Oncol., 4, 96, 10.3389/fonc.2014.00096 Krönke, 2015, Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS, Nature, 523, 183, 10.1038/nature14610 Richter, 2018, CK1alpha overexpression correlates with poor survival in colorectal cancer, BMC Cancer, 18, 140, 10.1186/s12885-018-4019-0 Lantermann, 2015, Inhibition of casein kinase 1 alpha prevents acquired drug resistance to erlotinib in EGFR-mutant non-small cell lung cancer, Cancer Res., 75, 4937, 10.1158/0008-5472.CAN-15-1113 Cohen, 2021, Kinase drug discovery 20 years after imatinib: progress and future directions, Nat. Rev. Drug Discov., 20, 551, 10.1038/s41573-021-00195-4 Wang, 2019, Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute, Nat. Protoc., 14, 756, 10.1038/s41596-018-0113-7 Hart, 2015, High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities, Cell, 163, 1515, 10.1016/j.cell.2015.11.015 Zhang, 2014, Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer, Cancer Res., 74, 6635, 10.1158/0008-5472.CAN-14-1916 Kato, 2016, Cotargeting androgen receptor splice variants and mTOR signaling pathway for the treatment of castration-resistant prostate cancer, Clin. Cancer Res., 22, 2744, 10.1158/1078-0432.CCR-15-2119 Lam, 2020, Durable response of enzalutamide-resistant prostate cancer to supraphysiological testosterone is associated with a multifaceted growth suppression and Impaired DNA damage response transcriptomic program in patient-derived xenografts, Eur. Urol., 77, 144, 10.1016/j.eururo.2019.05.042 Wengner, 2020, Targeting DNA damage response in prostate and breast cancer, Int. J. Mol. Sci., 21, 10.3390/ijms21218273 Abida, 2019, Genomic correlates of clinical outcome in advanced prostate cancer, Proc. Natl. Acad. Sci. USA, 116, 11428, 10.1073/pnas.1902651116 Gupta, 2021, Circulating tumor cell genomic evolution and hormone therapy outcomes in men with metastatic castration-resistant prostate cancer, Mol. Cancer Res., 19, 1040, 10.1158/1541-7786.MCR-20-0975 Li, 2017, Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer, Sci. Signal., 10, 10.1126/scisignal.aam7479 Minzel, 2018, Small molecules Co-targeting CKIalpha and the transcriptional kinases CDK7/9 control AML in preclinical models, Cell, 175, 171, 10.1016/j.cell.2018.07.045 Koh, 2010, MYC and prostate cancer, Genes Cancer, 1, 617, 10.1177/1947601910379132 Amit, 2002, Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway, Genes Dev., 16, 1066, 10.1101/gad.230302 Liu, 2002, Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism, Cell, 108, 837, 10.1016/S0092-8674(02)00685-2 Zhang, 2018, Inhibition of the wnt/beta-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer, Cancer Res., 78, 3147, 10.1158/0008-5472.CAN-17-3006 Elyada, 2011, CKIalpha ablation highlights a critical role for p53 in invasiveness control, Nature, 470, 409, 10.1038/nature09673 Pribluda, 2013, A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism, Cancer Cell, 24, 242, 10.1016/j.ccr.2013.06.005 Kounatidou, 2019, A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities, Nucleic Acids Res., 47, 5634, 10.1093/nar/gkz286 Polkinghorn, 2013, Androgen receptor signaling regulates DNA repair in prostate cancers, Cancer Discov., 3, 1245, 10.1158/2159-8290.CD-13-0172 Karanika, 2017, Targeting DNA damage response in prostate cancer by inhibiting androgen receptor-CDC6-ATR-chk1 signaling, Cell Rep., 18, 1970, 10.1016/j.celrep.2017.01.072 Blackford, 2017, ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response, Mol. Cell., 66, 801, 10.1016/j.molcel.2017.05.015 Vítor, 2020, Studying DNA double-strand break repair: an ever-growing toolbox, Front. Mol. Biosci., 7, 24, 10.3389/fmolb.2020.00024 Shieh, 1997, DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2, Cell, 91, 325, 10.1016/S0092-8674(00)80416-X Zhang, 2022, RB1, cancer lineage plasticity, and therapeutic resistance, Annu. Rev. Cell Biol., 6, 201, 10.1146/annurev-cancerbio-070120-092840 Mu, 2017, SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer, Science, 355, 84, 10.1126/science.aah4307 Rickman, 2017, Biology and evolution of poorly differentiated neuroendocrine tumors, Nat. Med., 23, 1, 10.1038/nm.4341 Sanjana, 2014, Improved vectors and genome-wide libraries for CRISPR screening, Nat. Methods, 11, 783, 10.1038/nmeth.3047 Wang, 2017, The p53 family coordinates Wnt and nodal inputs in mesendodermal differentiation of embryonic stem cells, Cell Stem Cell, 20, 70, 10.1016/j.stem.2016.10.002 Hong, 2016, Integrated genetic and pharmacologic interrogation of rare cancers, Nat. Commun., 7, 10.1038/ncomms11987 Canman, 1998, Activation of the ATM kinase by ionizing radiation and phosphorylation of p53, Science, 281, 1677, 10.1126/science.281.5383.1677 Doench, 2016, Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat. Biotechnol., 34, 184, 10.1038/nbt.3437 Wiederschain, 2009, Single-vector inducible lentiviral RNAi system for oncology target validation, Cell Cycle, 8, 498, 10.4161/cc.8.3.7701 Patil, 2018, CK1alpha and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma, Blood, 132, 577, 10.1182/blood-2018-01-828418 Stewart, 2003, Lentivirus-delivered stable gene silencing by RNAi in primary cells, RNA, 9, 493, 10.1261/rna.2192803 Li, 2015, Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR, Genome Biol., 16, 281, 10.1186/s13059-015-0843-6 Ritchie, 2015, Limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res., 43, e47, 10.1093/nar/gkv007 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, 102, 15545, 10.1073/pnas.0506580102 Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat. Methods, 9, 671, 10.1038/nmeth.2089 Kim, 2015, HISAT: a fast spliced aligner with low memory requirements, Nat. Methods, 12, 357, 10.1038/nmeth.3317 Liao, 2014, featureCounts: an efficient general purpose program for assigning sequence reads to genomic features, Bioinformatics, 30, 923, 10.1093/bioinformatics/btt656 Farah, 2019, NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells, J. Biol. Chem., 294, 8543, 10.1074/jbc.RA118.006983 Liu, 2020, p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer, Oncogene, 39, 3939, 10.1038/s41388-020-1270-z